Thierry Leveillard

2 Patents

• US118651892024

  Transgenic RPE Cells Overexpressing OTX2 for the Treatment of Retinal Degeneration

  INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)

  0 cites
• US117239882023

  Methods of Expressing a Polynucleotide of Interest in the Cone Photoreceptors of a Subject Comprising the Subretinal Delivery of a Therapeutically Effective Amount of a Recombinant Aav9-derived Vector

  SORBONNE UNIVERSITE

  0 cites